Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_67535327_67535478 | Egr2 | 73 | 0.960407 | 0.54 | 2.0e-05 | Click! |
chr10_67536503_67536814 | Egr2 | 1075 | 0.416744 | 0.45 | 6.0e-04 | Click! |
chr10_67535993_67536422 | Egr2 | 624 | 0.639150 | 0.43 | 1.1e-03 | Click! |
chr10_67536867_67537245 | Egr2 | 813 | 0.528655 | 0.28 | 3.9e-02 | Click! |
chr10_67538067_67538222 | Egr2 | 214 | 0.907643 | 0.21 | 1.3e-01 | Click! |
chr8_13338146_13338489 | Tfdp1 | 434 | 0.743157 | 0.70 | 3.4e-09 | Click! |
chr8_13338738_13339397 | Tfdp1 | 246 | 0.877592 | 0.42 | 1.3e-03 | Click! |
chr8_13352152_13352303 | Tfdp1 | 12553 | 0.115468 | -0.42 | 1.5e-03 | Click! |
chr8_13353323_13353495 | Tfdp1 | 11761 | 0.116716 | -0.39 | 2.8e-03 | Click! |
chr8_13354019_13354170 | Tfdp1 | 11076 | 0.117793 | -0.38 | 3.9e-03 | Click! |
chr2_105134384_105134593 | Wt1 | 3605 | 0.219747 | 0.35 | 9.0e-03 | Click! |
chr2_105126898_105127197 | Wt1 | 46 | 0.904819 | 0.24 | 8.1e-02 | Click! |
chr2_105132350_105132533 | Wt1 | 1558 | 0.368015 | 0.16 | 2.4e-01 | Click! |
chr2_105127208_105127384 | Wt1 | 86 | 0.927277 | 0.12 | 3.8e-01 | Click! |
chr2_105126173_105126893 | Wt1 | 4 | 0.500731 | 0.10 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 52.22 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr9_124439906_124440949 | 42.92 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr10_81559146_81561402 | 36.34 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr2_33130296_33131698 | 33.31 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr14_120830371_120830865 | 25.86 |
Gm9391 |
predicted gene 9391 |
3460 |
0.2 |
chr12_3236518_3237725 | 22.95 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_118812628_118813057 | 22.84 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chr9_86879639_86880662 | 22.32 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr17_13759899_13761731 | 21.82 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr19_36553934_36555231 | 21.77 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr19_38054215_38055320 | 21.37 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr7_81454347_81455042 | 20.40 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
19 |
0.95 |
chr15_39197089_39197893 | 20.37 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
770 |
0.61 |
chr15_64311804_64313067 | 19.70 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
204 |
0.93 |
chr12_112721309_112722969 | 18.93 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr2_181134637_181135435 | 18.90 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
91 |
0.95 |
chr1_3671269_3672324 | 18.75 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr2_132029196_132030408 | 18.73 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr13_13393240_13394314 | 18.70 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr2_102451171_102452295 | 18.65 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr2_151701768_151703133 | 18.25 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr14_6037512_6038662 | 18.11 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr7_79535477_79536145 | 17.83 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr13_12650037_12651101 | 17.80 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr7_44310178_44311500 | 17.77 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr5_23675895_23676511 | 17.70 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr3_32616403_32617072 | 17.63 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr12_111758304_111760062 | 17.60 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr14_34819764_34820558 | 17.58 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr9_90269973_90270914 | 17.50 |
Tbc1d2b |
TBC1 domain family, member 2B |
326 |
0.88 |
chr2_173658978_173659962 | 17.37 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr15_87543998_87544348 | 17.14 |
Tafa5 |
TAFA chemokine like family member 5 |
126 |
0.98 |
chr9_26733143_26733768 | 16.98 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr7_63444022_63445137 | 16.46 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr14_14350947_14351733 | 16.11 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr7_84409236_84410328 | 15.87 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr11_120721167_120722110 | 15.85 |
Rac3 |
Rac family small GTPase 3 |
65 |
0.91 |
chr8_11727589_11727958 | 15.80 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
52 |
0.95 |
chr4_59548682_59549911 | 15.76 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
1 |
0.64 |
chr1_16518910_16519418 | 15.61 |
Stau2 |
staufen double-stranded RNA binding protein 2 |
47 |
0.98 |
chr5_109556763_109557843 | 15.36 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr11_22858998_22860305 | 15.33 |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
106 |
0.89 |
chr10_70599218_70599723 | 15.27 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
179 |
0.96 |
chr3_127698278_127698609 | 15.21 |
Gm16238 |
predicted gene 16238 |
5923 |
0.12 |
chr2_94273064_94274137 | 15.16 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr2_17730264_17731671 | 15.12 |
Nebl |
nebulette |
76 |
0.98 |
chr10_90828740_90829725 | 14.97 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
111 |
0.96 |
chr5_65106807_65107827 | 14.95 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr8_46210360_46210863 | 14.94 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr7_38106770_38108111 | 14.88 |
Ccne1 |
cyclin E1 |
62 |
0.97 |
chr14_61172444_61173564 | 14.85 |
Sacs |
sacsin |
14 |
0.98 |
chr5_112239158_112239879 | 14.85 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr13_54788797_54789586 | 14.72 |
Tspan17 |
tetraspanin 17 |
186 |
0.91 |
chr7_84151018_84152417 | 14.69 |
Abhd17c |
abhydrolase domain containing 17C |
47 |
0.87 |
chr14_7244047_7245236 | 14.62 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr11_54303609_54304215 | 14.62 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr8_36457363_36458468 | 14.55 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr2_143545715_143546271 | 14.51 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr10_89872924_89873647 | 14.47 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
224 |
0.95 |
chr18_25678986_25679896 | 14.45 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr19_36409278_36410322 | 14.31 |
Pcgf5 |
polycomb group ring finger 5 |
52 |
0.97 |
chr15_100614796_100615700 | 14.22 |
Dazap2 |
DAZ associated protein 2 |
101 |
0.53 |
chr7_79499656_79500079 | 14.21 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chr10_32889642_32890523 | 14.19 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chrX_99975248_99976491 | 14.10 |
Eda |
ectodysplasin-A |
88 |
0.98 |
chr17_35836572_35837313 | 13.91 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr14_57525179_57526034 | 13.89 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr15_74563715_74564797 | 13.80 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
355 |
0.54 |
chr13_13783865_13785053 | 13.78 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr8_80738786_80739993 | 13.75 |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
36 |
0.98 |
chr17_8800581_8801529 | 13.70 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chr7_67372280_67373557 | 13.63 |
Mef2a |
myocyte enhancer factor 2A |
60 |
0.97 |
chr1_21078652_21079573 | 13.56 |
Tram2 |
translocating chain-associating membrane protein 2 |
117 |
0.93 |
chr8_125569269_125570645 | 13.52 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr14_18893044_18894412 | 13.39 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
10 |
0.98 |
chr13_48966851_48968700 | 13.15 |
Fam120a |
family with sequence similarity 120, member A |
242 |
0.95 |
chr14_4018192_4019443 | 13.03 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr5_8622909_8623205 | 13.01 |
Rundc3b |
RUN domain containing 3B |
105 |
0.97 |
chr6_122485766_122486276 | 12.99 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr5_108549866_108550582 | 12.99 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chr3_86920207_86921011 | 12.90 |
Dclk2 |
doublecortin-like kinase 2 |
230 |
0.91 |
chr2_167348597_167349642 | 12.89 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
64 |
0.98 |
chr7_63212002_63212745 | 12.85 |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
140 |
0.98 |
chr2_77816275_77817277 | 12.81 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr8_122281269_122282287 | 12.70 |
Zfpm1 |
zinc finger protein, multitype 1 |
363 |
0.84 |
chr18_23310224_23310683 | 12.67 |
Gm7788 |
predicted gene 7788 |
93784 |
0.08 |
chr5_37028527_37029187 | 12.66 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr2_152048577_152049360 | 12.46 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr14_4110111_4111235 | 12.42 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr7_105787328_105788039 | 12.38 |
Dchs1 |
dachsous cadherin related 1 |
29 |
0.95 |
chr6_127768794_127769871 | 12.37 |
Prmt8 |
protein arginine N-methyltransferase 8 |
140 |
0.91 |
chr12_26414308_26415459 | 12.36 |
Mir6538 |
microRNA 6538 |
127 |
0.66 |
chr1_25829654_25830461 | 12.22 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
350 |
0.61 |
chr4_11006925_11008291 | 12.19 |
Plekhf2 |
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
68 |
0.97 |
chr7_35754026_35754910 | 12.18 |
Dpy19l3 |
dpy-19-like 3 (C. elegans) |
14 |
0.98 |
chr6_122486412_122487163 | 12.16 |
Rimklb |
ribosomal modification protein rimK-like family member B |
282 |
0.86 |
chr9_53705535_53706804 | 12.11 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr2_54436378_54437149 | 12.06 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
272 |
0.95 |
chr15_64060029_64060819 | 12.06 |
Fam49b |
family with sequence similarity 49, member B |
4 |
0.98 |
chr5_38158989_38159808 | 12.05 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr6_18170355_18170889 | 12.03 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
65 |
0.97 |
chr10_77902919_77903521 | 11.99 |
Lrrc3 |
leucine rich repeat containing 3 |
684 |
0.44 |
chr1_22806069_22806442 | 11.85 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
261 |
0.95 |
chr1_175692535_175693373 | 11.70 |
Chml |
choroideremia-like |
53 |
0.67 |
chr6_121473518_121474161 | 11.66 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
161 |
0.96 |
chr7_57590461_57591180 | 11.65 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
302 |
0.92 |
chr12_113098320_113099412 | 11.62 |
Mta1 |
metastasis associated 1 |
465 |
0.7 |
chr9_86695289_86696275 | 11.62 |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
171 |
0.66 |
chr9_62536098_62537614 | 11.55 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr10_79533095_79534301 | 11.52 |
Plpp2 |
phospholipid phosphatase 2 |
59 |
0.95 |
chr9_122571793_122572853 | 11.52 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr7_34132383_34133715 | 11.47 |
Wtip |
WT1-interacting protein |
219 |
0.88 |
chr15_68928138_68928628 | 11.37 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
37 |
0.98 |
chr8_12873206_12874084 | 11.36 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr15_30172351_30173308 | 11.29 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
138 |
0.98 |
chr8_4212633_4214018 | 11.27 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr15_25364173_25365245 | 11.24 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
32050 |
0.14 |
chr8_70797005_70797670 | 11.19 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
349 |
0.6 |
chr4_120854573_120855281 | 11.18 |
Rims3 |
regulating synaptic membrane exocytosis 3 |
108 |
0.95 |
chr8_71670876_71671939 | 11.16 |
Unc13a |
unc-13 homolog A |
329 |
0.75 |
chr8_12396567_12397039 | 11.16 |
Gm25239 |
predicted gene, 25239 |
400 |
0.74 |
chr6_113195212_113195613 | 11.11 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
28 |
0.97 |
chrX_6047676_6048151 | 11.10 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
460 |
0.76 |
chr10_79613505_79614566 | 11.08 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr8_70476397_70477967 | 11.07 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr14_6426499_6427300 | 11.05 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
14417 |
0.14 |
chr4_152273539_152274471 | 11.02 |
Gpr153 |
G protein-coupled receptor 153 |
227 |
0.89 |
chr12_30372910_30373696 | 11.00 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr2_26932798_26934207 | 10.99 |
Surf4 |
surfeit gene 4 |
119 |
0.82 |
chr19_42431698_42432696 | 10.98 |
Crtac1 |
cartilage acidic protein 1 |
412 |
0.84 |
chr13_12105853_12107098 | 10.97 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
chr4_24966254_24966983 | 10.95 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
2 |
0.49 |
chrX_13461303_13461893 | 10.93 |
Nyx |
nyctalopin |
4512 |
0.22 |
chr3_33142428_33143483 | 10.90 |
Pex5l |
peroxisomal biogenesis factor 5-like |
121 |
0.97 |
chr1_33907825_33908362 | 10.86 |
Dst |
dystonin |
132 |
0.68 |
chr5_113908635_113909358 | 10.86 |
Coro1c |
coronin, actin binding protein 1C |
238 |
0.87 |
chr11_32220828_32222435 | 10.80 |
Rhbdf1 |
rhomboid 5 homolog 1 |
613 |
0.58 |
chr5_71095688_71096242 | 10.79 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
116 |
0.98 |
chr6_72958015_72959038 | 10.78 |
Tmsb10 |
thymosin, beta 10 |
38 |
0.97 |
chr19_53528895_53529902 | 10.77 |
Gm50394 |
predicted gene, 50394 |
257 |
0.52 |
chr8_32883706_32884108 | 10.76 |
Nrg1 |
neuregulin 1 |
45 |
0.99 |
chr7_109010582_109011352 | 10.76 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr5_14514560_14515558 | 10.76 |
Pclo |
piccolo (presynaptic cytomatrix protein) |
66 |
0.97 |
chr5_63968213_63969244 | 10.75 |
Rell1 |
RELT-like 1 |
95 |
0.96 |
chr14_122451015_122451402 | 10.75 |
Gm5089 |
predicted gene 5089 |
93 |
0.95 |
chr9_13246797_13247848 | 10.75 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr16_18629072_18630255 | 10.74 |
Septin5 |
septin 5 |
41 |
0.96 |
chr14_6889264_6890534 | 10.74 |
Gm3667 |
predicted gene 3667 |
63 |
0.97 |
chr14_3948585_3949537 | 10.72 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr8_17534538_17535388 | 10.68 |
Csmd1 |
CUB and Sushi multiple domains 1 |
318 |
0.95 |
chr10_84440183_84441378 | 10.67 |
Gm47962 |
predicted gene, 47962 |
46 |
0.68 |
chr11_79590966_79591301 | 10.64 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
79 |
0.95 |
chr14_39472717_39472908 | 10.63 |
Nrg3 |
neuregulin 3 |
13 |
0.99 |
chrX_150656289_150656688 | 10.61 |
Tro |
trophinin |
560 |
0.72 |
chr10_13982761_13983386 | 10.61 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr4_58911968_58912917 | 10.61 |
Ecpas |
Ecm29 proteasome adaptor and scaffold |
262 |
0.91 |
chr1_167000471_167001126 | 10.58 |
Gm16701 |
predicted gene, 16701 |
43 |
0.92 |
chr12_49383638_49384096 | 10.56 |
Foxg1 |
forkhead box G1 |
860 |
0.39 |
chr3_34649198_34650117 | 10.56 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr2_90885655_90886093 | 10.55 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
14 |
0.95 |
chr10_59701969_59702699 | 10.54 |
Micu1 |
mitochondrial calcium uptake 1 |
143 |
0.96 |
chr5_142701305_142702538 | 10.54 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
180 |
0.95 |
chr8_127063794_127064607 | 10.52 |
Pard3 |
par-3 family cell polarity regulator |
45 |
0.97 |
chr11_66526100_66526559 | 10.48 |
Shisa6 |
shisa family member 6 |
365 |
0.91 |
chr3_37419062_37420017 | 10.48 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
18 |
0.84 |
chr15_37006786_37007614 | 10.47 |
Zfp706 |
zinc finger protein 706 |
185 |
0.67 |
chr1_79858099_79859256 | 10.45 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
19 |
0.98 |
chr10_80179200_80179727 | 10.45 |
Efna2 |
ephrin A2 |
19 |
0.94 |
chr19_32755763_32756646 | 10.42 |
Pten |
phosphatase and tensin homolog |
1293 |
0.51 |
chr5_9100833_9101781 | 10.41 |
Tmem243 |
transmembrane protein 243, mitochondrial |
560 |
0.74 |
chr3_158561021_158562021 | 10.40 |
Lrrc7 |
leucine rich repeat containing 7 |
176 |
0.97 |
chr6_88841841_88842983 | 10.40 |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
428 |
0.42 |
chr8_46470414_46471778 | 10.32 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
24 |
0.97 |
chr8_128685293_128686190 | 10.27 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
16 |
0.98 |
chr3_62338522_62339494 | 10.26 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
9 |
0.97 |
chr6_17693827_17694982 | 10.23 |
St7 |
suppression of tumorigenicity 7 |
237 |
0.9 |
chr4_116016940_116018214 | 10.22 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr10_79716268_79716706 | 10.21 |
Hcn2 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
147 |
0.88 |
chr12_105336634_105337535 | 10.19 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
91 |
0.97 |
chr3_40949219_40949942 | 10.17 |
Larp1b |
La ribonucleoprotein domain family, member 1B |
248 |
0.88 |
chr15_25842982_25843686 | 10.15 |
Retreg1 |
reticulophagy regulator 1 |
154 |
0.95 |
chr1_182763880_182764492 | 10.10 |
Susd4 |
sushi domain containing 4 |
174 |
0.95 |
chr4_14930150_14931008 | 10.10 |
Gm11837 |
predicted gene 11837 |
82 |
0.98 |
chr4_22487751_22488274 | 10.09 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
354 |
0.84 |
chr4_78211506_78212633 | 10.09 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
108 |
0.5 |
chr5_86172175_86173131 | 10.08 |
Uba6 |
ubiquitin-like modifier activating enzyme 6 |
86 |
0.97 |
chrX_60404083_60404984 | 10.07 |
Atp11c |
ATPase, class VI, type 11C |
552 |
0.78 |
chr11_98959522_98960759 | 10.06 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr10_83722468_83723424 | 10.05 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr2_168679330_168679584 | 9.96 |
Atp9a |
ATPase, class II, type 9A |
9111 |
0.21 |
chr14_5388691_5389629 | 9.94 |
Gm3500 |
predicted gene 3500 |
111 |
0.95 |
chr11_80080470_80081713 | 9.91 |
Crlf3 |
cytokine receptor-like factor 3 |
100 |
0.96 |
chr15_74672233_74673425 | 9.89 |
Arc |
activity regulated cytoskeletal-associated protein |
259 |
0.85 |
chr7_16285532_16286609 | 9.86 |
Ccdc9 |
coiled-coil domain containing 9 |
45 |
0.95 |
chr2_68471780_68472489 | 9.86 |
Stk39 |
serine/threonine kinase 39 |
134 |
0.96 |
chr10_76961851_76962568 | 9.85 |
Pcbp3 |
poly(rC) binding protein 3 |
322 |
0.87 |
chr4_46991653_46992403 | 9.85 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
155 |
0.95 |
chr17_27203606_27204996 | 9.84 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr8_104170477_104170924 | 9.84 |
Bean1 |
brain expressed, associated with Nedd4, 1 |
117 |
0.94 |
chr13_49147195_49148263 | 9.84 |
Wnk2 |
WNK lysine deficient protein kinase 2 |
283 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.6 | 37.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.5 | 57.7 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
10.0 | 29.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
8.9 | 8.9 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
8.0 | 56.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
8.0 | 32.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
7.7 | 46.3 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
7.4 | 22.3 | GO:0046959 | habituation(GO:0046959) |
7.1 | 21.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
6.9 | 20.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
6.9 | 54.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
6.8 | 20.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.4 | 6.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
6.4 | 25.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
6.1 | 18.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
6.1 | 24.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
6.0 | 11.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
5.9 | 17.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
5.9 | 5.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
5.9 | 17.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
5.9 | 17.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
5.8 | 17.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
5.7 | 28.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.7 | 11.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
5.7 | 17.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
5.6 | 16.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
5.6 | 11.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
5.6 | 16.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
5.5 | 16.5 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
5.4 | 16.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
5.4 | 16.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.4 | 21.7 | GO:0007412 | axon target recognition(GO:0007412) |
5.4 | 16.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
5.3 | 10.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.3 | 21.4 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
5.3 | 42.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
5.3 | 15.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
5.2 | 31.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
5.1 | 25.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
5.1 | 15.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
4.9 | 9.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
4.8 | 14.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
4.8 | 9.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.8 | 23.8 | GO:0021764 | amygdala development(GO:0021764) |
4.8 | 14.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
4.7 | 18.9 | GO:0021747 | cochlear nucleus development(GO:0021747) |
4.7 | 18.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
4.7 | 4.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
4.6 | 13.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
4.6 | 13.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
4.6 | 27.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
4.6 | 32.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
4.6 | 13.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.6 | 13.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.6 | 18.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.6 | 36.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.5 | 13.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.5 | 4.5 | GO:0090135 | actin filament branching(GO:0090135) |
4.5 | 18.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
4.5 | 22.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
4.5 | 13.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
4.5 | 13.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
4.4 | 17.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
4.4 | 4.4 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
4.3 | 8.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.3 | 13.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
4.3 | 8.7 | GO:0046958 | nonassociative learning(GO:0046958) |
4.3 | 17.1 | GO:0090427 | activation of meiosis(GO:0090427) |
4.3 | 29.8 | GO:1901660 | calcium ion export(GO:1901660) |
4.2 | 51.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
4.2 | 12.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
4.2 | 12.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
4.2 | 12.5 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
4.1 | 12.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
4.0 | 8.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.0 | 16.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
4.0 | 20.0 | GO:0003192 | mitral valve formation(GO:0003192) |
4.0 | 11.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
4.0 | 11.9 | GO:0030070 | insulin processing(GO:0030070) |
4.0 | 11.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.9 | 19.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.9 | 19.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.8 | 15.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.8 | 7.7 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
3.8 | 3.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.7 | 3.7 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
3.7 | 3.7 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
3.7 | 14.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
3.7 | 7.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
3.7 | 3.7 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
3.6 | 10.9 | GO:0021564 | vagus nerve development(GO:0021564) |
3.6 | 10.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
3.6 | 7.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.6 | 10.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
3.5 | 17.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.5 | 10.6 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) positive regulation of metanephric glomerulus development(GO:0072300) |
3.5 | 10.5 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
3.5 | 10.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
3.5 | 10.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.4 | 3.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
3.4 | 10.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.4 | 6.8 | GO:0032898 | neurotrophin production(GO:0032898) |
3.4 | 20.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.4 | 10.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
3.4 | 16.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.3 | 3.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
3.3 | 13.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.3 | 3.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
3.3 | 6.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
3.3 | 13.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
3.3 | 13.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.3 | 9.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
3.3 | 3.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.3 | 6.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
3.3 | 13.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.3 | 9.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
3.2 | 13.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
3.2 | 6.5 | GO:0048880 | sensory system development(GO:0048880) |
3.2 | 12.9 | GO:0003139 | secondary heart field specification(GO:0003139) |
3.2 | 6.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
3.2 | 3.2 | GO:1903416 | response to glycoside(GO:1903416) |
3.2 | 3.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.2 | 15.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
3.2 | 9.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
3.2 | 9.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
3.2 | 3.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
3.2 | 6.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
3.1 | 25.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.1 | 18.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.1 | 9.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
3.1 | 9.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.1 | 3.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
3.1 | 15.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.1 | 9.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
3.1 | 21.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
3.1 | 9.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.1 | 9.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
3.1 | 9.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.1 | 12.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
3.1 | 9.2 | GO:0015888 | thiamine transport(GO:0015888) |
3.1 | 9.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
3.1 | 6.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.0 | 18.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
3.0 | 9.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
3.0 | 3.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
3.0 | 51.2 | GO:0035640 | exploration behavior(GO:0035640) |
3.0 | 3.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
3.0 | 12.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.0 | 8.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.9 | 5.9 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
2.9 | 2.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.9 | 11.8 | GO:0003383 | apical constriction(GO:0003383) |
2.9 | 61.7 | GO:0001964 | startle response(GO:0001964) |
2.9 | 2.9 | GO:0060166 | olfactory pit development(GO:0060166) |
2.9 | 14.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.9 | 8.7 | GO:0097503 | sialylation(GO:0097503) |
2.9 | 8.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
2.9 | 5.8 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
2.9 | 46.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.9 | 8.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.8 | 25.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.8 | 2.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.8 | 11.4 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
2.8 | 8.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.8 | 11.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.8 | 14.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.8 | 8.4 | GO:0008355 | olfactory learning(GO:0008355) |
2.8 | 27.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.8 | 2.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
2.8 | 8.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
2.8 | 8.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
2.7 | 11.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.7 | 8.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
2.7 | 5.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
2.7 | 2.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
2.7 | 5.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.7 | 10.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.7 | 2.7 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
2.7 | 42.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.7 | 8.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
2.7 | 5.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.7 | 8.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.6 | 10.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.6 | 5.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.6 | 18.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.6 | 2.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.6 | 149.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.6 | 2.6 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
2.6 | 13.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.6 | 7.7 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.6 | 7.7 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.6 | 5.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.6 | 7.7 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
2.5 | 7.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.5 | 12.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.5 | 12.4 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
2.5 | 2.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
2.5 | 2.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
2.5 | 7.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.5 | 4.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.5 | 4.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.4 | 9.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
2.4 | 24.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
2.4 | 4.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
2.4 | 2.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
2.4 | 2.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
2.4 | 4.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.4 | 41.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.4 | 7.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.4 | 9.6 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.4 | 9.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.4 | 9.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.4 | 9.5 | GO:0060437 | lung growth(GO:0060437) |
2.4 | 4.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.3 | 2.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.3 | 2.3 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.3 | 4.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.3 | 9.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
2.3 | 4.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.3 | 6.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.3 | 16.1 | GO:0006108 | malate metabolic process(GO:0006108) |
2.3 | 6.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.3 | 11.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.3 | 11.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.3 | 6.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.3 | 11.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.3 | 6.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.3 | 13.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
2.3 | 2.3 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
2.3 | 22.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.2 | 20.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.2 | 4.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.2 | 4.4 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
2.2 | 19.8 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
2.2 | 30.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.2 | 22.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
2.2 | 8.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.2 | 2.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.2 | 8.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
2.2 | 2.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.2 | 4.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.2 | 19.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.2 | 6.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.2 | 6.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.2 | 21.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
2.2 | 2.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
2.2 | 12.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.2 | 4.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
2.2 | 12.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
2.2 | 15.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
2.1 | 27.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.1 | 8.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.1 | 4.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.1 | 4.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.1 | 8.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
2.1 | 4.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
2.1 | 8.4 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
2.1 | 4.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.1 | 4.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.1 | 6.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.1 | 2.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.1 | 8.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.1 | 6.2 | GO:0035106 | operant conditioning(GO:0035106) |
2.1 | 4.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.0 | 12.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
2.0 | 6.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.0 | 8.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.0 | 10.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
2.0 | 58.1 | GO:0019228 | neuronal action potential(GO:0019228) |
2.0 | 2.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
2.0 | 4.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
2.0 | 4.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
2.0 | 4.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
2.0 | 15.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
2.0 | 9.9 | GO:0033762 | response to glucagon(GO:0033762) |
2.0 | 2.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.0 | 5.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.0 | 21.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
2.0 | 7.9 | GO:0021854 | hypothalamus development(GO:0021854) |
2.0 | 27.5 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
2.0 | 5.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.9 | 5.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.9 | 33.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.9 | 7.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.9 | 3.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.9 | 3.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.9 | 7.7 | GO:0030035 | microspike assembly(GO:0030035) |
1.9 | 11.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.9 | 144.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.9 | 15.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.9 | 7.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.9 | 5.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.9 | 1.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.9 | 9.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.9 | 13.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.9 | 18.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.9 | 7.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.9 | 3.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.9 | 9.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.9 | 29.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.9 | 11.1 | GO:0060736 | prostate gland growth(GO:0060736) |
1.8 | 5.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.8 | 1.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.8 | 1.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.8 | 3.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.8 | 1.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.8 | 1.8 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
1.8 | 5.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.8 | 5.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.8 | 7.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.8 | 25.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.8 | 3.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.8 | 1.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.8 | 1.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.8 | 7.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.8 | 12.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.8 | 7.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.8 | 5.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.8 | 1.8 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.8 | 8.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.7 | 22.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.7 | 10.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.7 | 3.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 3.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.7 | 3.5 | GO:0051665 | membrane raft localization(GO:0051665) |
1.7 | 3.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.7 | 6.9 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
1.7 | 1.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.7 | 5.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.7 | 3.5 | GO:0061743 | motor learning(GO:0061743) |
1.7 | 5.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.7 | 6.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.7 | 1.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.7 | 5.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.7 | 8.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.7 | 6.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.7 | 3.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.7 | 3.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.7 | 8.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.7 | 8.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.7 | 8.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.7 | 5.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.7 | 5.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.7 | 3.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.7 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.7 | 5.0 | GO:0021794 | thalamus development(GO:0021794) |
1.7 | 3.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.7 | 5.0 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
1.7 | 18.2 | GO:0036065 | fucosylation(GO:0036065) |
1.7 | 11.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
1.6 | 1.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.6 | 1.6 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.6 | 4.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.6 | 4.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.6 | 4.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.6 | 9.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.6 | 4.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.6 | 9.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.6 | 3.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.6 | 11.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.6 | 3.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.6 | 3.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.6 | 8.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.6 | 3.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.6 | 4.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.6 | 9.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.6 | 14.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.6 | 1.6 | GO:0044320 | leptin-mediated signaling pathway(GO:0033210) cellular response to leptin stimulus(GO:0044320) |
1.6 | 4.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.6 | 4.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.6 | 9.4 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.6 | 14.0 | GO:0060004 | reflex(GO:0060004) |
1.6 | 3.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.6 | 7.8 | GO:0035989 | tendon development(GO:0035989) |
1.6 | 7.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
1.6 | 9.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.5 | 6.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.5 | 6.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
1.5 | 4.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.5 | 4.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.5 | 3.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.5 | 15.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.5 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
1.5 | 3.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.5 | 6.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.5 | 7.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.5 | 6.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.5 | 157.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.5 | 3.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.5 | 9.0 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
1.5 | 10.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.5 | 1.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
1.5 | 5.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.5 | 1.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.5 | 4.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.5 | 7.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
1.5 | 5.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.5 | 36.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.5 | 13.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.5 | 4.4 | GO:0014028 | notochord formation(GO:0014028) |
1.5 | 2.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 5.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.5 | 5.8 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
1.5 | 18.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.5 | 11.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.4 | 5.8 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.4 | 2.9 | GO:0016264 | gap junction assembly(GO:0016264) |
1.4 | 1.4 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.4 | 21.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.4 | 8.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.4 | 21.4 | GO:0006491 | N-glycan processing(GO:0006491) |
1.4 | 15.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 1.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.4 | 5.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.4 | 6.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.4 | 1.4 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.4 | 1.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.4 | 11.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.4 | 4.1 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.4 | 1.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.4 | 2.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.4 | 10.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.4 | 2.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 4.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.4 | 4.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.4 | 4.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.3 | 6.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 4.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.3 | 6.7 | GO:0015884 | folic acid transport(GO:0015884) |
1.3 | 13.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.3 | 4.0 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 2.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.3 | 1.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.3 | 3.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.3 | 2.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.3 | 11.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.3 | 1.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.3 | 9.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 1.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
1.3 | 2.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 11.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.3 | 15.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.3 | 3.9 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.3 | 5.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.3 | 7.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.3 | 5.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.3 | 38.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.3 | 2.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.3 | 7.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.3 | 3.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.3 | 6.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.2 | 7.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 1.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.2 | 3.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.2 | 1.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.2 | 2.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.2 | 9.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
1.2 | 3.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.2 | 4.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 3.6 | GO:0002254 | kinin cascade(GO:0002254) |
1.2 | 2.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.2 | 2.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
1.2 | 6.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.2 | 6.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.2 | 1.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.2 | 12.0 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.2 | 9.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.2 | 6.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.2 | 1.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.2 | 11.9 | GO:0010842 | retina layer formation(GO:0010842) |
1.2 | 4.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.2 | 2.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.2 | 5.9 | GO:0015808 | L-alanine transport(GO:0015808) |
1.2 | 7.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.2 | 15.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
1.2 | 1.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 3.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.2 | 12.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.2 | 3.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.1 | 1.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
1.1 | 3.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 16.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.1 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.1 | 3.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
1.1 | 5.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 2.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.1 | 4.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.1 | 5.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.1 | 3.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.1 | 4.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.1 | 6.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 3.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.1 | 2.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.1 | 6.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.1 | 8.9 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
1.1 | 1.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.1 | 2.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.1 | 6.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.1 | 3.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
1.1 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.1 | 2.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.1 | 4.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.1 | 2.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.1 | 4.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.1 | 2.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.1 | 4.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.1 | 1.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.1 | 3.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.1 | 6.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.0 | 6.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 3.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.0 | 4.2 | GO:0035627 | ceramide transport(GO:0035627) |
1.0 | 13.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.0 | 2.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.0 | 4.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.0 | 1.0 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.0 | 4.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.0 | 4.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.0 | 17.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 3.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.0 | 4.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.0 | 5.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
1.0 | 2.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
1.0 | 3.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
1.0 | 3.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.0 | 3.0 | GO:0051013 | microtubule severing(GO:0051013) |
1.0 | 3.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.0 | 7.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.0 | 7.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.0 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.0 | 5.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.0 | 6.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.0 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 5.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.0 | 3.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.0 | 3.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.0 | 3.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 4.0 | GO:0006983 | ER overload response(GO:0006983) |
1.0 | 5.0 | GO:0031033 | myosin filament organization(GO:0031033) |
1.0 | 3.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 9.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.0 | 5.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 13.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
1.0 | 2.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.0 | 2.0 | GO:0035425 | autocrine signaling(GO:0035425) |
1.0 | 5.9 | GO:0051775 | response to redox state(GO:0051775) |
1.0 | 6.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.0 | 2.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.0 | 1.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
1.0 | 1.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.0 | 5.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
1.0 | 3.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.0 | 1.9 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
1.0 | 1.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.0 | 1.0 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
1.0 | 1.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.0 | 1.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.0 | 8.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.9 | 2.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.9 | 4.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.9 | 2.8 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.9 | 1.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 4.7 | GO:0097009 | energy homeostasis(GO:0097009) |
0.9 | 3.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.9 | 1.9 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.9 | 2.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.9 | 1.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 59.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.9 | 3.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.9 | 15.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.9 | 2.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.9 | 4.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.9 | 2.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.9 | 5.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.9 | 1.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.9 | 8.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.9 | 22.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.9 | 6.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.9 | 0.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.9 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.9 | 9.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.9 | 1.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 3.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 1.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.9 | 4.4 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.9 | 4.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.9 | 2.7 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.9 | 6.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.9 | 1.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 7.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.9 | 0.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.9 | 4.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 2.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.9 | 4.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 6.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.9 | 2.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.9 | 6.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.9 | 1.7 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.9 | 6.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.9 | 2.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.9 | 4.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.8 | 5.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.8 | 0.8 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.8 | 3.4 | GO:0038001 | paracrine signaling(GO:0038001) |
0.8 | 1.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.8 | 2.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.8 | 9.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.8 | 8.3 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 5.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.8 | 3.3 | GO:0060914 | heart formation(GO:0060914) |
0.8 | 2.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 0.8 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.8 | 2.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 7.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.8 | 1.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.8 | 2.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.8 | 1.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.8 | 4.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.8 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.8 | 1.6 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.8 | 5.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.8 | 2.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.8 | 0.8 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 3.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.8 | 2.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.8 | 2.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.8 | 7.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.8 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 4.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.8 | 3.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 0.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 2.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 1.5 | GO:0086004 | regulation of cardiac muscle cell contraction(GO:0086004) |
0.8 | 3.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 3.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.8 | 16.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.8 | 9.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.8 | 3.0 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.8 | 6.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 7.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.7 | 10.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.7 | 3.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.7 | 0.7 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.7 | 2.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.7 | 2.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 0.7 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.7 | 3.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 2.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.7 | 11.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.7 | 0.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.7 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.7 | 9.5 | GO:0051647 | nucleus localization(GO:0051647) |
0.7 | 4.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 3.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.7 | 1.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.7 | 0.7 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 1.4 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.7 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 3.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 0.7 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.7 | 3.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.7 | 1.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.7 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.7 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.7 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.7 | 1.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 3.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.7 | 3.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.7 | 1.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 12.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.7 | 1.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 3.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 0.7 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.7 | 1.4 | GO:1904729 | regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.7 | 3.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.7 | 2.0 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 4.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 3.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.7 | 1.3 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 2.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 2.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.7 | 11.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.7 | 5.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.7 | 5.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.6 | 7.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.6 | 2.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 12.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 2.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 1.9 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.6 | 1.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.6 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.6 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.6 | 0.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.6 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 3.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 3.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.6 | 1.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.6 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 1.8 | GO:0007614 | short-term memory(GO:0007614) |
0.6 | 5.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.6 | 1.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.6 | 3.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 3.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 10.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.6 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.6 | 2.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 1.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 1.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.6 | 1.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 3.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 4.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 1.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 4.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.6 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.6 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 5.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.6 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 9.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.6 | 1.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 9.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 4.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.6 | 4.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 1.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.6 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 0.6 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.6 | 1.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.6 | 2.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.6 | 1.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.6 | 3.3 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.6 | 3.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.6 | 1.1 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.6 | 4.4 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.6 | 3.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.6 | 1.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.6 | 5.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 2.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 1.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.5 | 13.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 4.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 1.6 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.5 | 3.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.5 | 1.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 2.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.5 | 8.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.5 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 1.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 1.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.5 | 2.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 2.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 5.9 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.5 | 2.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 8.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 1.0 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.5 | 1.6 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.5 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 4.6 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.5 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 5.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 2.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 0.5 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.5 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 1.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.5 | 2.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 | 4.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.5 | 1.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 3.5 | GO:0090382 | phagosome maturation(GO:0090382) |
0.5 | 2.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 4.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 8.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.5 | 1.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.5 | 10.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.5 | 5.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 4.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.5 | 1.0 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.5 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 6.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 2.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 1.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 1.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 1.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.5 | 2.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 2.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 3.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.5 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 1.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 10.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.5 | 0.9 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.5 | 26.4 | GO:0001764 | neuron migration(GO:0001764) |
0.5 | 0.9 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.5 | 3.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.5 | 6.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.5 | 0.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 1.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 2.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 2.7 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.5 | 2.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 2.3 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.4 | 1.3 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.4 | 2.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 2.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.4 | 2.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 3.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 2.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 5.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 0.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.4 | 1.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.4 | 1.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 5.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.4 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 1.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 0.4 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.4 | 0.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 1.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 0.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 1.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.4 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 1.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 0.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.4 | 8.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.4 | 1.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 6.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 1.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.4 | 2.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.4 | 4.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.4 | 9.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 1.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.4 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 2.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.4 | 1.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 1.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.4 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.4 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 0.4 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.4 | 1.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 0.7 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 2.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.4 | 2.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 4.3 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.4 | 1.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 2.9 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.4 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.4 | 5.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 3.9 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 1.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 7.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 4.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 27.4 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.3 | 1.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.3 | 9.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.3 | 0.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.2 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.3 | 0.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 0.6 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.3 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.3 | 2.9 | GO:0007031 | peroxisome organization(GO:0007031) |
0.3 | 0.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 2.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.3 | 0.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.8 | GO:0003283 | atrial septum development(GO:0003283) |
0.3 | 0.8 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.8 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 2.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.5 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 3.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 0.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 0.5 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.3 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 1.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 3.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 1.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.9 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.2 | 4.5 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 1.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.2 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.2 | 0.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.4 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 0.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.9 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 1.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 1.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.8 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 1.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.2 | GO:0090193 | positive regulation of glomerulus development(GO:0090193) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.4 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.2 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.9 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 0.4 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.8 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.2 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 1.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.2 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 1.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 1.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.2 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.2 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 1.6 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.2 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 6.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.6 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 9.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 3.0 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 6.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 5.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 1.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0032071 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 2.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 2.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.9 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.1 | 0.6 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 1.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.7 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.4 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 1.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.1 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 2.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.4 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 2.7 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) regulation of cholesterol import(GO:0060620) cholesterol import(GO:0070508) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.0 | GO:0044851 | hair cycle phase(GO:0044851) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 1.5 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.5 | GO:0015844 | monoamine transport(GO:0015844) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.2 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.9 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.0 | GO:0061307 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 1.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 46.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
6.8 | 20.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
6.5 | 19.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
6.4 | 185.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
6.3 | 75.7 | GO:0043194 | axon initial segment(GO:0043194) |
5.4 | 85.9 | GO:0030673 | axolemma(GO:0030673) |
5.4 | 21.5 | GO:0000322 | storage vacuole(GO:0000322) |
5.2 | 15.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
5.2 | 5.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.2 | 15.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.1 | 40.8 | GO:0043083 | synaptic cleft(GO:0043083) |
4.9 | 4.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.2 | 12.6 | GO:0043511 | inhibin complex(GO:0043511) |
4.1 | 57.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.1 | 151.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.8 | 38.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.8 | 102.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.6 | 14.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
3.4 | 10.3 | GO:0072534 | perineuronal net(GO:0072534) |
3.4 | 136.0 | GO:0043198 | dendritic shaft(GO:0043198) |
3.4 | 10.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.4 | 13.4 | GO:1990246 | uniplex complex(GO:1990246) |
3.3 | 6.7 | GO:0016600 | flotillin complex(GO:0016600) |
3.1 | 9.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.1 | 12.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
3.1 | 3.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
3.1 | 30.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
2.9 | 17.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.9 | 11.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.9 | 11.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.8 | 5.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.8 | 22.4 | GO:0005883 | neurofilament(GO:0005883) |
2.8 | 11.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.7 | 11.0 | GO:0071203 | WASH complex(GO:0071203) |
2.7 | 8.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.7 | 161.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.7 | 8.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.7 | 10.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.6 | 21.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.6 | 7.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.5 | 12.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.5 | 10.1 | GO:0045298 | tubulin complex(GO:0045298) |
2.4 | 21.9 | GO:0000124 | SAGA complex(GO:0000124) |
2.4 | 9.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.4 | 11.8 | GO:0043219 | lateral loop(GO:0043219) |
2.3 | 2.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.3 | 2.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.2 | 24.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.2 | 8.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.2 | 8.7 | GO:0097422 | tubular endosome(GO:0097422) |
2.1 | 15.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.1 | 17.1 | GO:0031209 | SCAR complex(GO:0031209) |
2.1 | 28.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.0 | 2.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.0 | 2.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
2.0 | 16.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.0 | 8.0 | GO:0030478 | actin cap(GO:0030478) |
1.9 | 11.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.9 | 5.8 | GO:0036396 | MIS complex(GO:0036396) |
1.9 | 9.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.9 | 3.8 | GO:0044308 | axonal spine(GO:0044308) |
1.9 | 51.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.9 | 240.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.9 | 5.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.8 | 3.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.8 | 16.6 | GO:0097440 | apical dendrite(GO:0097440) |
1.8 | 18.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.8 | 1.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.8 | 7.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.8 | 7.0 | GO:0042583 | chromaffin granule(GO:0042583) |
1.8 | 15.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.7 | 17.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 20.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.7 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 6.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.7 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.7 | 5.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.7 | 54.7 | GO:0034704 | calcium channel complex(GO:0034704) |
1.6 | 19.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
1.6 | 140.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.6 | 9.7 | GO:0071437 | invadopodium(GO:0071437) |
1.6 | 4.8 | GO:0032437 | cuticular plate(GO:0032437) |
1.6 | 8.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.6 | 4.8 | GO:0097513 | myosin II filament(GO:0097513) |
1.6 | 1.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.6 | 6.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.6 | 3.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.5 | 1.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.5 | 3.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.5 | 4.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.5 | 15.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.5 | 6.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.5 | 7.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.5 | 11.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.4 | 17.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.4 | 4.3 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 7.2 | GO:0045180 | basal cortex(GO:0045180) |
1.4 | 5.7 | GO:0070876 | SOSS complex(GO:0070876) |
1.4 | 8.5 | GO:0031901 | early endosome membrane(GO:0031901) |
1.4 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.4 | 5.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.4 | 84.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.3 | 1.3 | GO:0032280 | symmetric synapse(GO:0032280) |
1.3 | 19.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.3 | 6.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.3 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.2 | 7.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.2 | 7.2 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 3.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.2 | 4.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.2 | 7.1 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 8.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.2 | 124.3 | GO:0098794 | postsynapse(GO:0098794) |
1.2 | 5.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.2 | 7.0 | GO:0060076 | excitatory synapse(GO:0060076) |
1.2 | 3.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.2 | 12.7 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 2.3 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.1 | 6.8 | GO:0016589 | NURF complex(GO:0016589) |
1.1 | 4.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.1 | 16.8 | GO:0000145 | exocyst(GO:0000145) |
1.1 | 10.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.1 | 13.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.1 | 26.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.1 | 3.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.1 | 6.4 | GO:0030008 | TRAPP complex(GO:0030008) |
1.1 | 8.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.1 | 12.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.1 | 8.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.0 | 6.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.0 | 3.1 | GO:0071942 | XPC complex(GO:0071942) |
1.0 | 3.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 1.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 2.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.0 | 2.0 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 3.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.0 | 2.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.0 | 3.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 3.9 | GO:0097433 | dense body(GO:0097433) |
1.0 | 2.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.0 | 4.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 3.9 | GO:0032021 | NELF complex(GO:0032021) |
1.0 | 2.9 | GO:0005955 | calcineurin complex(GO:0005955) |
1.0 | 10.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.0 | 13.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.0 | 3.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.9 | 4.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.9 | 3.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.9 | 2.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 39.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 1.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.9 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.9 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 3.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.9 | 3.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.9 | 12.3 | GO:0030904 | retromer complex(GO:0030904) |
0.9 | 18.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.9 | 5.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.9 | 118.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.9 | 3.5 | GO:0000938 | GARP complex(GO:0000938) |
0.8 | 11.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.8 | 12.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.8 | 1.6 | GO:0005767 | secondary lysosome(GO:0005767) |
0.8 | 5.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 47.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.8 | 7.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 3.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.8 | 3.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.8 | 5.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.8 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 1.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.8 | 6.2 | GO:0000243 | commitment complex(GO:0000243) |
0.8 | 3.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.8 | 9.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 25.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.7 | 3.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 19.8 | GO:0030175 | filopodium(GO:0030175) |
0.7 | 20.3 | GO:0005921 | gap junction(GO:0005921) |
0.7 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 3.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 2.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 8.3 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 34.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.7 | 30.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.7 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 6.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 2.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.7 | 3.3 | GO:0033503 | HULC complex(GO:0033503) |
0.7 | 0.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.7 | 3.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 2.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 17.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 2.6 | GO:0089701 | U2AF(GO:0089701) |
0.6 | 18.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.6 | 9.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 3.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.6 | 4.4 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 1.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.6 | 6.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.6 | 4.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 1.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 3.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.6 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 26.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.6 | 2.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 1.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 4.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 14.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.6 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 8.0 | GO:0000800 | lateral element(GO:0000800) |
0.6 | 1.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 2.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 80.5 | GO:0045202 | synapse(GO:0045202) |
0.5 | 0.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.5 | 2.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 6.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 8.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 5.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 2.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 3.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.5 | 4.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 7.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.5 | 2.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 23.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 14.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 1.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 4.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 4.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 7.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 1.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 5.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.4 | 1.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 3.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 4.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 2.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 9.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 4.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.4 | 2.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 2.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 5.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 4.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 2.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 1.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.5 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 5.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 2.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 7.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 3.2 | GO:0002102 | podosome(GO:0002102) |
0.4 | 14.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 5.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 3.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 26.9 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 1.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.5 | GO:0043679 | axon terminus(GO:0043679) |
0.3 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 15.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.5 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 2.6 | GO:0001741 | XY body(GO:0001741) |
0.3 | 1274.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.3 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 2.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 15.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 15.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 3.7 | GO:0044440 | endosomal part(GO:0044440) |
0.2 | 7.4 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.2 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 9.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 5.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 3.0 | GO:0030894 | replisome(GO:0030894) |
0.2 | 4.3 | GO:0030135 | coated vesicle(GO:0030135) |
0.2 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 7.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 2.5 | GO:0030496 | midbody(GO:0030496) |
0.2 | 5.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 4.8 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 9.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.9 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 9.3 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.0 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 13.6 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 4.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 5.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 9.2 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 5.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
10.0 | 30.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
9.3 | 28.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
8.8 | 35.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
8.5 | 16.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
8.4 | 25.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
8.1 | 24.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
7.4 | 22.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
7.3 | 22.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
7.2 | 21.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
6.8 | 20.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
6.8 | 20.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
6.8 | 33.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
6.6 | 26.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
6.2 | 31.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
5.9 | 17.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
5.9 | 5.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
5.7 | 28.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.6 | 5.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
5.5 | 10.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.3 | 26.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.9 | 14.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.9 | 19.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.7 | 9.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.7 | 9.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
4.6 | 106.3 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
4.5 | 22.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
4.5 | 35.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.4 | 17.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
4.4 | 13.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
4.3 | 8.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
4.2 | 12.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
4.2 | 20.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
4.1 | 24.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.0 | 20.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
3.9 | 7.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.9 | 117.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.9 | 15.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.8 | 15.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
3.7 | 3.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.7 | 44.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
3.6 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
3.6 | 17.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.5 | 7.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.5 | 28.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.5 | 13.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
3.5 | 13.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.4 | 3.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.4 | 13.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
3.4 | 16.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.4 | 10.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.3 | 66.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.3 | 9.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
3.2 | 12.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.2 | 12.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.2 | 12.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.1 | 9.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.1 | 12.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.1 | 3.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.1 | 6.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.1 | 9.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.0 | 29.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.0 | 17.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
3.0 | 3.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
3.0 | 38.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
3.0 | 5.9 | GO:0043398 | HLH domain binding(GO:0043398) |
2.9 | 5.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.9 | 8.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.9 | 20.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.8 | 2.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
2.8 | 8.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.8 | 8.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.8 | 2.8 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
2.8 | 8.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.7 | 5.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.7 | 38.2 | GO:0031402 | sodium ion binding(GO:0031402) |
2.7 | 10.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 8.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.7 | 8.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.7 | 13.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.6 | 15.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.6 | 7.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.6 | 7.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.6 | 13.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.6 | 10.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.6 | 12.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.5 | 20.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.5 | 2.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
2.5 | 9.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.4 | 9.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 2.4 | GO:0030371 | translation repressor activity(GO:0030371) |
2.4 | 2.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
2.4 | 36.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.4 | 19.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.4 | 14.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.3 | 11.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.3 | 7.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.3 | 7.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.3 | 7.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.3 | 6.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.3 | 9.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
2.3 | 9.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.3 | 9.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.3 | 29.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.3 | 9.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.3 | 20.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.2 | 2.2 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
2.2 | 17.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.2 | 15.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.2 | 6.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.2 | 6.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.2 | 6.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.1 | 10.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
2.1 | 14.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.1 | 12.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.1 | 14.6 | GO:0034711 | inhibin binding(GO:0034711) |
2.1 | 6.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.1 | 51.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.0 | 12.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
2.0 | 16.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.0 | 4.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
2.0 | 6.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.0 | 10.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
2.0 | 17.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.0 | 7.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.0 | 15.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
2.0 | 25.5 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
1.9 | 23.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.9 | 5.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.9 | 5.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.9 | 21.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.9 | 49.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.9 | 13.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.9 | 5.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.9 | 7.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.9 | 9.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.9 | 3.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 7.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.8 | 39.9 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.8 | 5.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.8 | 12.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.8 | 5.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.8 | 7.2 | GO:0097001 | ceramide binding(GO:0097001) |
1.8 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.8 | 7.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.8 | 22.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.8 | 15.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.8 | 19.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.8 | 7.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.7 | 36.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.7 | 7.0 | GO:0070728 | leucine binding(GO:0070728) |
1.7 | 8.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.7 | 1.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.7 | 3.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.7 | 16.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.7 | 5.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.7 | 18.3 | GO:0005522 | profilin binding(GO:0005522) |
1.6 | 69.3 | GO:0030276 | clathrin binding(GO:0030276) |
1.6 | 3.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.6 | 18.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 1.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.6 | 6.4 | GO:0030955 | potassium ion binding(GO:0030955) |
1.6 | 6.4 | GO:0016151 | nickel cation binding(GO:0016151) |
1.6 | 4.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.6 | 7.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.6 | 4.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.6 | 4.7 | GO:0050693 | LBD domain binding(GO:0050693) |
1.6 | 4.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.6 | 4.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.5 | 16.9 | GO:0015643 | toxic substance binding(GO:0015643) |
1.5 | 1.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.5 | 4.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.5 | 4.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.5 | 47.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.5 | 22.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.5 | 69.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.5 | 19.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.5 | 16.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.5 | 3.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.5 | 7.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.5 | 6.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.5 | 7.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.5 | 5.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.5 | 1.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.5 | 14.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.5 | 5.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.5 | 4.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.5 | 1.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.4 | 1.4 | GO:0051378 | serotonin binding(GO:0051378) |
1.4 | 18.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.4 | 5.8 | GO:0019808 | polyamine binding(GO:0019808) |
1.4 | 5.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.4 | 18.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.4 | 4.3 | GO:2001070 | starch binding(GO:2001070) |
1.4 | 9.9 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.4 | 18.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.4 | 4.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.4 | 4.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 5.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.4 | 4.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.4 | 1.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
1.4 | 6.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.4 | 6.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.4 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.4 | 4.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
1.4 | 2.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 5.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.4 | 4.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 5.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.4 | 4.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.3 | 4.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.3 | 17.4 | GO:0070402 | NADPH binding(GO:0070402) |
1.3 | 6.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.3 | 85.2 | GO:0044325 | ion channel binding(GO:0044325) |
1.3 | 3.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.3 | 5.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.3 | 3.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.3 | 3.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 5.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.3 | 7.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.2 | 3.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.2 | 8.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.2 | 2.5 | GO:2001069 | glycogen binding(GO:2001069) |
1.2 | 3.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.2 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.2 | 7.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.2 | 8.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 10.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.2 | 3.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 14.1 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 8.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.2 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.2 | 9.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.2 | 12.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.2 | 1.2 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
1.2 | 8.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 3.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.2 | 26.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.1 | 16.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.1 | 13.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.1 | 7.9 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 5.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.1 | 3.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.1 | 9.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.1 | 5.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 7.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
1.1 | 1.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
1.1 | 4.4 | GO:0070052 | collagen V binding(GO:0070052) |
1.1 | 30.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.1 | 10.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.1 | 4.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.1 | 9.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.1 | 4.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
1.1 | 4.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.0 | 1.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.0 | 4.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 4.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.0 | 7.3 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 4.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.0 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 9.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.0 | 13.4 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
1.0 | 6.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.0 | 3.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.0 | 4.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.0 | 4.1 | GO:1990254 | keratin filament binding(GO:1990254) |
1.0 | 25.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
1.0 | 7.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.0 | 14.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.0 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 14.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
1.0 | 5.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 2.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.0 | 11.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.0 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.0 | 8.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.0 | 4.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 25.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.0 | 5.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 5.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.0 | 3.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.0 | 9.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.0 | 2.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 7.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.0 | 7.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 4.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 2.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.9 | 13.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.9 | 0.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.9 | 2.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.9 | 3.7 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.9 | 3.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.9 | 1.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.9 | 10.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.9 | 17.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 2.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.9 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 3.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 8.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.9 | 3.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 6.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 7.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.9 | 2.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.8 | 1.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.8 | 67.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 10.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 37.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.8 | 3.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.8 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.8 | 9.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.8 | 8.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.8 | 2.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.8 | 3.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 4.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.8 | 5.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.8 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.8 | 27.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.8 | 3.2 | GO:0016594 | glycine binding(GO:0016594) |
0.8 | 3.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.8 | 3.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.8 | 1.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 21.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.8 | 0.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.8 | 3.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.8 | 2.3 | GO:0034929 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.8 | 3.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 3.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 15.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.8 | 9.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 1.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 5.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.7 | 11.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 8.8 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.7 | 3.7 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 9.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 13.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.7 | 7.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 4.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 1.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.7 | 13.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.7 | 2.9 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 6.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 3.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 5.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.7 | 0.7 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.7 | 6.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 3.4 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.7 | 12.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 3.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.7 | 9.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 19.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 8.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 3.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 3.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 2.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 31.4 | GO:0017022 | myosin binding(GO:0017022) |
0.7 | 3.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.7 | 2.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 0.6 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 3.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 2.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 15.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 6.3 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.6 | 10.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 3.7 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.6 | 8.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.6 | 6.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.6 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 4.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 16.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 1.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 1.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.6 | 1.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 1.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.6 | 3.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 17.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 1.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.6 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 5.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.6 | 2.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 4.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.6 | 5.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 6.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.6 | 9.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.6 | 10.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 2.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 7.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.6 | 1.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 3.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 1.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.6 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 6.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 22.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 3.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 2.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 7.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 1.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 42.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.5 | 22.3 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 3.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 5.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.5 | 2.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 5.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 4.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 2.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.5 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 1.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 2.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 9.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.5 | 1.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.5 | 1.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 1.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 13.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 1.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 44.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 1.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 3.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 5.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 4.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 3.7 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.5 | 2.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.3 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 7.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 1.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.5 | 11.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.5 | 7.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 1.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 4.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 5.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.4 | 2.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 14.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.4 | 2.2 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 5.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.4 | 1.7 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.4 | 2.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 0.4 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.4 | 4.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.4 | 2.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 7.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 4.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.6 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 5.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 0.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 1.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 0.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 4.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 6.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 6.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 46.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 1.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 3.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 2.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 1.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 6.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 5.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 2.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 11.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 4.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 0.7 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.3 | 0.7 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.3 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.3 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 3.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 3.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 7.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 2.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 5.7 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 2.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 6.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 7.8 | GO:0015297 | antiporter activity(GO:0015297) |
0.3 | 4.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 3.8 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 14.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 2.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 3.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 11.0 | GO:0001653 | peptide receptor activity(GO:0001653) |
0.2 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 46.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.1 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 5.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 2.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.4 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 6.3 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 4.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 1.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 9.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.8 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.2 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.0 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 41.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 54.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 4.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 3.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 2.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 2.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 11.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 3.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 3.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 9.1 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 1.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 2.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 1.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.7 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 2.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 1.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 3.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 12.3 | PID REELIN PATHWAY | Reelin signaling pathway |
5.2 | 10.3 | PID INSULIN PATHWAY | Insulin Pathway |
3.2 | 3.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
2.5 | 5.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.5 | 37.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.2 | 2.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.0 | 57.0 | PID AURORA A PATHWAY | Aurora A signaling |
1.9 | 51.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.6 | 4.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.6 | 26.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.4 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.4 | 24.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.4 | 18.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.3 | 34.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 5.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.1 | 23.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.0 | 9.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.0 | 20.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 27.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 40.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.9 | 11.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 11.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 8.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 3.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.8 | 5.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.8 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 9.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 20.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 16.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 8.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 15.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 13.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.8 | 34.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.7 | 7.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.7 | 5.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 10.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 2.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 11.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 15.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.6 | 8.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 8.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 16.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 2.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.5 | 3.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 11.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 4.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 4.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 11.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 8.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 5.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 1.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 12.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 12.2 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 10.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 5.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 44.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 11.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 10.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 5.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
5.0 | 60.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
4.8 | 4.8 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
4.3 | 64.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
4.3 | 90.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
4.2 | 12.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.2 | 45.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.0 | 4.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
4.0 | 39.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.7 | 51.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
3.6 | 149.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.6 | 39.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.5 | 49.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.2 | 28.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.8 | 30.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.7 | 37.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.5 | 35.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.3 | 61.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
2.3 | 18.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.3 | 9.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.3 | 18.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.1 | 17.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.1 | 14.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.0 | 30.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.0 | 22.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.0 | 50.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
2.0 | 19.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
2.0 | 45.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.0 | 21.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.9 | 17.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.8 | 40.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.8 | 1.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.8 | 29.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.8 | 15.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.7 | 42.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.7 | 42.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.6 | 18.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.5 | 6.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.5 | 22.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.4 | 14.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.4 | 11.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.4 | 11.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.4 | 15.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.4 | 16.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 6.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 23.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.3 | 2.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.3 | 12.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.3 | 20.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.3 | 11.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.3 | 17.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.2 | 8.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.1 | 7.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.1 | 7.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.0 | 33.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.0 | 8.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 3.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 18.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.0 | 7.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 6.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 10.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.9 | 15.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.9 | 45.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.9 | 42.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.9 | 77.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.8 | 0.8 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.8 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 14.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 9.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.8 | 6.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.8 | 3.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.8 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.7 | 17.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 6.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 27.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.7 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.7 | 6.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 7.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 13.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 4.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 1.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.7 | 6.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 6.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 1.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 5.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 16.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 3.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 8.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 8.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.6 | 17.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.6 | 6.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 13.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.6 | 11.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.6 | 1.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.6 | 1.7 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.5 | 8.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 4.2 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 7.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.5 | 8.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 31.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.5 | 12.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 6.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 6.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 6.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 7.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 5.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 2.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 4.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 8.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 8.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.5 | 2.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.5 | 1.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.4 | 5.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 9.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 1.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.4 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 4.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 4.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 4.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 6.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 4.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.4 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 5.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 5.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 3.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 4.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 14.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 4.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 7.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 0.8 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 2.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 9.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 13.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 17.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 12.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 6.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 5.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 7.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 17.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |